You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Advanced Hepatocellular Carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Hepatocellular Carcinoma Trial (CD-801)

Not yet recruiting
  • Advanced Hepatocellular Carcinoma
  • (no location specified)
Oct 13, 2023

Advanced Hepatocellular Carcinoma Trial (SZ003 CAR-NK)

Not yet recruiting
  • Advanced Hepatocellular Carcinoma
  • SZ003 CAR-NK
  • (no location specified)
Apr 25, 2023

Advanced Hepatocellular Carcinoma Trial in Guangzhou (adebrelimab, camrelizumab plus apatinib)

Not yet recruiting
  • Advanced Hepatocellular Carcinoma
  • adebrelimab, camrelizumab plus apatinib
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital
Jun 21, 2023

Hepatocellular Carcinoma Trial in Guangzhou (Lenvatinib, Tislelizumab Combined with RALOX Regimen HAIC)

Recruiting
  • Hepatocellular Carcinoma
  • Lenvatinib, Tislelizumab Combined with RALOX Regimen HAIC
  • Guangzhou, Guangdong, China
    Guangdong Provincial People's Hospital
Jul 12, 2023

Hepatocellular Carcinoma Trial in Shanghai (BC3402 injection, Durvalumab injection)

Not yet recruiting
  • Hepatocellular Carcinoma
  • BC3402 injection
  • Durvalumab injection
  • Shanghai, China
    Zhongshan Hospital, Fudan University
Oct 26, 2023

Advanced Hepatocellular Carcinoma Trial (Tegavivint, Pembrolizumab)

Not yet recruiting
  • Advanced Hepatocellular Carcinoma
  • (no location specified)
Mar 21, 2023

HepaSphere Drug-eluting Bead Transarterial Chemoembolization

Recruiting
  • Advanced Hepatocellular Carcinoma (HCC)
  • DEB-TACE plus HAIC or HAIC alone
  • Beijing, Beijing, China
    Beijing Cancer Hospital
May 19, 2023

Advanced Hepatocellular Carcinoma That Has Failed at Systemic Therapy Trial in Tianjin (Cadonilimab Injection, Ramucirumab

Recruiting
  • Advanced Hepatocellular Carcinoma That Has Failed at Systemic Therapy
  • Cadonilimab Injection
  • Ramucirumab Injection
  • Tianjin, Tianjin, China
    Tianjin Cancer Hospital Airport Hospital
May 14, 2023

Advanced Hepatocellular Carcinoma Trial in Zhuhai (GDKM-100 injection)

Withdrawn
  • Advanced Hepatocellular Carcinoma
  • GDKM-100 injection
  • Zhuhai, Guangdong, China
    Zhuhai People'S Hospital
Jan 16, 2023

Hepatocellular Carcinoma Trial in Shanghai (Anlotinib and TQB2450)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Anlotinib and TQB2450
  • Shanghai, Shanghai, China
    Zhongshan hospital
Sep 4, 2023

Hepatocellular Carcinoma Trial in Seoul (AtezoBev with combined radiotherapy)

Not yet recruiting
  • Hepatocellular Carcinoma
  • AtezoBev with combined radiotherapy
  • Seoul, Korea, Republic of
    Severance hospital
Jun 9, 2023

Liver Carcinoma, Hepatic Cell Carcinoma Trial in Wuhan (CAR-GPC3 T cells)

Recruiting
  • Liver Carcinoma
  • Hepatic Cell Carcinoma
  • CAR-GPC3 T cells
  • Wuhan, Hubei, China
    Tao Zhang
Nov 20, 2023

Advanced Hepatocellular Carcinoma Trial in Beijing (Neoantigen vaccine, I.M injection)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • Neoantigen vaccine, I.M injection
  • Beijing, Beijing, China
    Peking Union Medical College Hospital, Chinese Academy of Medica
Jul 31, 2023

Hepatocellular Carcinoma Trial in Shanghai (CAR-GPC3 T cells)

Recruiting
  • Hepatocellular Carcinoma
  • CAR-GPC3 T cells
  • Shanghai, China
    Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong Universi
Jun 22, 2023

Advanced Hepatocellular Carcinoma Trial in Shenzhen (GPC3 CAR-T cells)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • GPC3 CAR-T cells
  • Shenzhen, Guangdong, China
    Li Yu
Nov 17, 2022

Advanced Hepatocellular Carcinoma Trial in Chengdu (Lenvatinib combined with TACE and Camrelizumab)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • Lenvatinib combined with TACE and Camrelizumab
  • Chengdu, Sichuan, China
    HuaXi hospital
Feb 12, 2023

Liver Cancer, Hepatocellular Carcinoma Trial (Regorafenib Oral Product)

Not yet recruiting
  • Liver Cancer
  • Hepatocellular Carcinoma
  • Regorafenib Oral Product
  • (no location specified)
Nov 17, 2022

Hepatocellular Carcinoma Trial in Tianjin (HAIC, Adebrelimab, Bevacizumab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • HAIC
  • +2 more
  • Tianjin, Tianjin, China
    Tianjin Cancer Hospital Airport Hospital
Jul 27, 2023

Hepatocellular Carcinoma Trial in Nanjing, Shanghai (QL1706, Bevacizumab, Oxaliplatin injection)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Nanjing, Jiangsu, China
  • +1 more
Jul 28, 2023

Advanced Hepatocellular Carcinoma Trial (Sorafenib)

Enrolling by invitation
  • Advanced Hepatocellular Carcinoma
  • Seoul, Korea, Republic of
    National Cancer Center, Korea
Oct 19, 2022

Hepatocellular Carcinoma Trial (Oncorine, Tislelizumab, Lenvatinib)

Not yet recruiting
  • Hepatocellular Carcinoma
  • (no location specified)
Jan 30, 2023

Advanced Hepatocellular Carcinoma Trial in Shanghai (Tislelizumab, lenvatinib, US/CT-guided Percutaneous Cryoablation)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 8, 2022

Advanced Hepatocellular Carcinoma That Has Failed at Least One Prior Systemic Therapy Trial in Tianjin (Cadonilimab Injection,

Recruiting
  • Advanced Hepatocellular Carcinoma That Has Failed at Least One Prior Systemic Therapy
  • Tianjin, Tianjin, China
    Tianjin Cancer Hospital Airport Hospital
Dec 7, 2022

Advanced Hepatocellular Carcinoma Trial (EU307 CAR-T Cell)

Not yet recruiting
  • Advanced Hepatocellular Carcinoma
  • EU307 CAR-T Cell
  • (no location specified)
Mar 13, 2023

Nephrotoxicity Trial (Huaier Granule, VEGFR-TKIs)

Not yet recruiting
  • Nephrotoxicity
  • (no location specified)
Jan 5, 2023